Jingxian Wang Selected Research

2,3,7,8-tetrabromodibenzo-4-dioxin

4/2007

Effects of brominated flame retardants and brominated dioxins on steroidogenesis in H295R human adrenocortical carcinoma cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jingxian Wang Research Topics

Disease

3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 08/2014
3	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2021 - 02/2020
3	Hemorrhage 01/2020 - 12/2016
3	Shock 01/2020 - 12/2016
2	Neoplasms (Cancer) 03/2024 - 01/2019
2	Memory Disorders (Memory Loss) 10/2018 - 12/2016
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 03/2024
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2024
1	Stomach Neoplasms (Stomach Cancer) 03/2024
1	Liver Neoplasms (Liver Cancer) 03/2024
1	Cholangiocarcinoma 03/2024
1	Rectal Neoplasms (Rectal Cancer) 03/2024
1	Carcinoma (Carcinomatosis) 03/2024
1	Paresthesia (Dysesthesia) 12/2022
1	Idiopathic Pulmonary Fibrosis 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Disease Progression 12/2020
1	Lung Injury 02/2020
1	Hemorrhagic Shock 01/2020
1	Reperfusion Injury 01/2020
1	Asthma (Bronchial Asthma) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 01/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2019
1	Brain Injuries (Brain Injury) 10/2018
1	Edema (Dropsy) 01/2017
1	Ischemia 12/2016
1	Brain Ischemia (Cerebral Ischemia) 12/2016
1	Extrapulmonary Tuberculosis 05/2014
1	Pulmonary Tuberculosis 05/2014
1	Macular Degeneration (Age-Related Maculopathy) 04/2014
1	Adrenocortical Carcinoma 04/2007
1	Coronary Disease (Coronary Heart Disease) 10/2002

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
3	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 12/2016
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 12/2016
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2014
2	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 09/2021 - 12/2020
2	AntigensIBA 02/2020 - 05/2014
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2014 - 08/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2024
1	lenvatinibIBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	AtractylosideIBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	Mitochondrial Permeability Transition PoreIBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Lipoxygenase (Lipoxygenase-1)IBA 01/2019
1	EicosanoidsIBA 01/2019
1	CateninsIBA 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 10/2018
1	Superoxide DismutaseIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	Interleukin-1 (Interleukin 1)IBA 01/2017
1	PowdersIBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014
1	2,3,7,8-tetrabromodibenzo-4-dioxinIBA 04/2007
1	Flame Retardants (Fire Retardants)IBA 04/2007
1	EnzymesIBA 04/2007
1	Polybrominated BiphenylsIBA 04/2007
1	DioxinsIBA 04/2007
1	Plasminogen Activators (Plasminogen Activator)IBA 10/2002

Therapy/Procedure

3	Resuscitation 01/2020 - 12/2016
1	Punctures 12/2022
1	Therapeutics 12/2020